InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: sokol post# 81920

Sunday, 12/04/2016 9:52:37 AM

Sunday, December 04, 2016 9:52:37 AM

Post# of 461277
The session will also give PK-PD data. This data will allow them to use for dose optimization - so the next trial may be p2b/3 which can have monotherapy + 2 A2-73 doses per day which may give better results.

That may be the reason the next trial is not started -use this data to refine the protocol before starting the trial
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News